Journal articles on the topic 'CAM Use and Vaccination'
To see the other types of publications on this topic, follow the link: CAM Use and Vaccination.
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'CAM Use and Vaccination.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
1
Deml, Michael J., Léna G. Dietrich, Bernhard Wingeier, Gisela Etter, Caesar Gallmann, Christoph Berger, L. Suzanne Suggs, Benedikt M. Huber, and Philip E. Tarr. "Collaborating with Complementary and Alternative Medicine (CAM) Providers When Writing HPV Vaccine Review Articles." Journal of Clinical Medicine 9, no. 2 (February 21, 2020): 592. http://dx.doi.org/10.3390/jcm9020592.
Full textAbstract:
Novel strategies are needed to address vaccine hesitancy (VH), which correlates with complementary and alternative medicine (CAM). In Switzerland, CAM providers play important roles in vaccine counseling of vaccine hesitant (VH) parents, and traditional vaccination messaging tends to overlook CAM provider perspectives. In the setting of a Swiss national research program on VH, our key strategy has been to work together closely with CAM providers. To assess the feasibility of generating educational human papillomavirus (HPV) vaccine materials that would interest VH healthcare providers (HCPs), we invited four CAM providers to co-author two HPV vaccine review articles for general practitioners. We conducted thematic analysis of CAM provider comments to identify patterns that could complement and improve vaccination messaging from CAM perspectives. We identified several themes and generated an inventory of CAM provider messaging recommendations related to language use, presentation of background information, nuanced statements regarding HPV vaccine efficacy and safety, and communication tools that would be important to VH HCPs. Contrary to our initial expectations, and in an inclusive, respectful atmosphere of open dialogue, we were able to productively finalize our manuscripts. In the opinion of the CAM co-authors, the manuscripts effectively considered the communication needs and perspectives of VH HCPs. Engaging with CAM providers appears to be a feasible and innovative avenue for providing vaccine information and designing communication tools aimed at VH healthcare providers.
2
Mini, G. K., Chitra A. Grace, and Lordson Jinbert. "Complementary and alternative medicine use in the prevention of COVID-19 pandemic: a cross-sectional survey in Kerala, India." International Journal Of Community Medicine And Public Health 8, no. 11 (October 27, 2021): 5329. http://dx.doi.org/10.18203/2394-6040.ijcmph20214267.
Full textAbstract:
Background: Globally, there is evidence of increased Complementary and alternative medicine (CAM) use during epidemics, and pandemics. Recent studies have shown that there is an increased use of CAM during the coronavirus disease (COVID-19) pandemic. The aim of the study was to investigate the pattern of CAM practice in the prevention of COVID-19 pandemic among adults in Kerala state, India.Methods: This was a cross-sectional descriptive study conducted in the first week of June 2021 among adults residing in Kerala state. The study used a pre-tested google form to collect the data. A total of 548 individuals aged 18-84 years answered an online questionnaire for the present study.Results: A higher proportion (52.4%) of participants were aged <30 years, 30.8% were males, 55.3% rural residents, 26.6% health care professionals, and 51.1% had a regular income. CAM use prevalence was 59.3% (95% CI: 55.1 to 63.3). Social media (46.9%) was the most frequently reported source of CAM. The age-adjusted analysis results showed that CAM use was higher among health professionals (OR: 2.15, 95% CI: 1.41-3.27), those who did not believe that vaccine could prevent coronavirus (OR: 1.91 CI: 1.08-3.39), and those who were having no regular income (OR: 1.56, CI: 1.04-2.34), compared to their counterparts.Conclusions: Close to 60% of CAM use in this population is a public health concern since the efficacy of CAM use for the prevention or treatment of COVID-19 is not known. The CAM users will be under a sense of false protection, which is likely to negate vaccination and seeking proper treatment for COVID -19 in Kerala.
3
Bendezu-Quispe, Guido, Jerry K. Benites-Meza, Diego Urrunaga-Pastor, Percy Herrera-Añazco, Angela Uyen-Cateriano, Alfonso J. Rodriguez-Morales, Carlos J. Toro-Huamanchumo, Adrian V. Hernandez, and Vicente A. Benites-Zapata. "Consumption of Herbal Supplements or Homeopathic Remedies to Prevent COVID-19 and Intention of Vaccination for COVID-19 in Latin America and the Caribbean." Tropical Medicine and Infectious Disease 7, no. 6 (June 8, 2022): 95. http://dx.doi.org/10.3390/tropicalmed7060095.
Full textAbstract:
Users of complementary and alternative medicine (CAM) have a lower intention to receive vaccines. Furthermore, Latin America and the Caribbean (LAC) region are among the most affected areas by the COVID-19 pandemics and present a high proportion of CAM users. Therefore, this study evaluates the association between the consumption of herbal supplements or homeopathic remedies to prevent COVID-19 and the intention to vaccinate against COVID-19 in the LAC region. We conducted a secondary data analysis of a Massachusetts Institute of Technology (MIT) survey with Facebook to assess COVID-19 beliefs, behaviours, and norms. Crude and adjusted prevalence ratios (aPR) with their respective 95% confidence intervals (95% CI) were calculated using generalized linear models of the Poisson family with the log link function. The prevalence of the use of products to prevent COVID-19 was the following: consumption of herbal supplements (7.2%), use of homeopathic remedies (4.8%), and consumption of garlic, ginger, and lemon (11.8%). An association was found between using herbal supplements (19.0% vs. 12.8%; aPR = 1.44; 95% CI: 1.30–1.58), the use of homeopathic remedies (20.3% vs. 12.3%; aPR = 1.58; 95% CI: 1.25–1.98), and the consumption of garlic, ginger, and lemon (18.9% vs. 11.9%; aPR = 1.55; 95% CI: 1.50–1.61) and non-intention to vaccinate against COVID-19. In the LAC population, there is an association between using herbal supplements, using homeopathic remedies and consuming garlic, ginger, and lemon to prevent infection by COVID-19 and non-intention to vaccinate against this disease. Therefore, it is necessary to design targeted strategies for groups that consume these products as preventive measures against COVID-19 to increase vaccination coverage and expand the information regarding transmission and prevention strategies for SARS-CoV-2.
4
Barenghi, Livia, Alberto Barenghi, Umberto Garagiola, Alberto Di Blasio, Aldo Bruno Giannì, and Francesco Spadari. "Pros and Cons of CAD/CAM Technology for Infection Prevention in Dental Settings during COVID-19 Outbreak." Sensors 22, no. 1 (December 22, 2021): 49. http://dx.doi.org/10.3390/s22010049.
Full textAbstract:
The purpose of this commentary is to update the evidence reported in our previous review on the advantages and limitations of computer-aided design/computer-aided manufacturing technology in the promotion of dental business, as well as to guarantee patient and occupational safety. The COVID-19 pandemic led to an unprecedented focus on infection prevention; however, waves of COVID-19 follow one another, asymptomatic cases are nearly impossible to identify by triage in a dental setting, and the effectiveness of long-lasting immune protection through vaccination remains largely unknown. Different national laws and international guidelines (mainly USA-CDC, ECDC) have often brought about dissimilar awareness and operational choices, and in general, there has been very limited attention to this technology. Here, we discuss its advantages and limitations in light of: (a) presence of SARS-CoV-2 in the oral cavity, saliva, and dental biofilm and activation of dormant microbial infections; (b) the prevention of SARS-CoV-2 transmission by aerosol and fomite contamination; (c) the detection of various oral manifestations of COVID-19; (d) specific information for the reprocessing of the scanner tip and the ward from the manufacturers.
5
Graham, Donna M., Wanrudee Isaranuwatchai, Steven Habbous, Claire de Oliveira, Geoffrey Liu, Lillian L. Siu, and Jeffrey S. Hoch. "A preliminary cost-effectiveness analysis of human papillomavirus vaccination in males for the prevention of oropharyngeal cancer." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 6033. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.6033.
Full textAbstract:
6033 Background: Many western countries have established female human papillomavirus (HPV) vaccination programmes for prevention of cervix cancer. Efficacy against additional HPV-related disease is proven in both sexes, but cost-effectiveness of male vaccination remains controversial. Projected figures suggest incidence and prevalence of oropharyngeal cancer (OPC) in North America will exceed that of cervix cancer by 2020 due to HPV-related cases. Two cost-effectiveness analyses evaluating male HPV vaccination have included OPC, with contrasting results. The Canadian government recommends, but does not fund, male vaccination. In order to assess the value for money of male HPV vaccination in Canada with respect to OPC, we performed a preliminary cost-effectiveness analysis. Methods: Following extensive literature review regarding HPV-related OPC in Canadian males, healthcare cost and clinical effectiveness estimates were obtained from published studies. A Markov model was used to compare potential costs and effectiveness of HPV vaccination against no vaccination among males aged 12 years old. A 3-month cycle length was used with a ‘lifetime’ time horizon. The outcome of the analysis was the incremental cost per quality-adjusted life-year (QALY). Sensitivity analyses were conducted on variables such as vaccine uptake rate and efficacy. Results: Assuming 99% vaccine efficacy and 70% uptake, the use of HPV vaccine produced 0.05 more QALYs and saved $204 Canadian dollars (CAD) per person compared with no vaccine (QALYs and costs discounted at 5% per year). Assuming 50% vaccine efficacy and 50% uptake, use of HPV vaccine produced 0.01 more QALYs and saved $43 CAD. Based on a population of 12 year old males of 192,940 in 2012, male HPV vaccination may potentially save $8.3-39.4 million CAD for this cohort over its lifetime. Conclusions: Knowledge gaps exist regarding male HPV vaccination for OPC prevention. Due to practical limitations, including lack of identifiable precursor lesions in OPC, clinical trials to evaluate this issue may not be feasible. Without considering the effects of herd immunity, this preliminary analysis highlights potential savings from male vaccination.
6
Nizam, Jinsa, B. G. Parasuramalu, and Shashikala Manjunatha. "Assessment of adherence to COVID appropriate behavior among post-vaccinated individuals in rural practice area of Raja Rajeswari medical college and hospital, Bengaluru." International Journal Of Community Medicine And Public Health 9, no. 3 (February 28, 2022): 1474. http://dx.doi.org/10.18203/2394-6040.ijcmph20220716.
Full textAbstract:
Background: As per observations related to the highly mutant corona virus, being vaccinated does not mean that people can avoid COVID preventive rules and guidance and put themselves and others at risk. The study aimed to assess adherence to COVID appropriate behaviour (CAB) among COVID vaccinated individuals in the rural field practice area of Raja Rajeswari medical college and hospital, Bengaluru.Methods: Community-based, cross-sectional descriptive study was conducted from 1 September to 31 November. A semi-structured, pre-tested, interviewer administered tool was used.Results: Out of 2285 study participants, the mean age of participants was 42±16 years. About 56% of participants were female and majority belonged to middle class. The most common measure adhered by the study participants was proper use of mask 94% and 70% before and after COVID vaccination respectively.Conclusions: Of 17 CAB practices, the adherence found to be reduced after vaccination among study participants.
7
Lee, Su-Bin, Ji-Yeon Kim, Kyusik Kim, Kyoung-Jin Ahn, Tae-il Kim, and Jae-Min Oh. "Encapsulation and Release Control of Fish Pathogen Utilizing Cross-Linked Alginate Networks and Clay Nanoparticles for Use with a Potential Oral Vaccination." Applied Sciences 10, no. 8 (April 13, 2020): 2679. http://dx.doi.org/10.3390/app10082679.
Full textAbstract:
Streptococcus parauberis is utilized as an oral vaccine by first inactivating the cells with formalin to produce formalin- killed cells (FKC) and then encapsulating them with polymer beads consisting of a cross-linked alginate-Ca2+ network. The encapsulation efficiency and media-dependent release are controlled by pre-treating the FKC with two types of clay nanoparticles: kaolinite (KA) and layered double hydroxide (LDH). The addition of LDH induced large agglomerates of FKC, and the KA enhanced the dispersion of FKC. The differences in the dispersibility of the FKC upon the use of clay nanoparticles was determined to strongly affect the encapsulation efficiency and release properties. The FKC + LDH mixture exhibited a slightly reduced encapsulation efficiency compared to the FKC alone. However, FKC + KA exhibited a dramatically improved encapsulation efficiency. In terms of the media-dependent release, the alginate beads were found to be fairly stable under gastric conditions and in deionized water with or without clay nanoparticles, preserving most of the encapsulated FKC. The intestine was the final target organ for FKC vaccination, and release at the site varied according to the use of clay nanoparticles. Both clays seemed to enhance the release of FKC, the cumulative amount being 3.6 times and 1.3 times larger for LDH and KA, respectively, than was shown with only FKC encapsulated beads.
8
Islam, Sk Injamamul, Sarower Mahfuj, Md Jakiul Islam, Moslema Jahan Mou, and Saloa Sanjida. "Use of Integrated Core Proteomics, Immuno-Informatics, and In Silico Approaches to Design a Multiepitope Vaccine against Zoonotic Pathogen Edwardsiella tarda." Applied Microbiology 2, no. 2 (June 18, 2022): 414–37. http://dx.doi.org/10.3390/applmicrobiol2020031.
Full textAbstract:
Multidrug-resistant Edwardsiella tarda has been reported as the main causative agent for massive fish mortality. The pathogen is well-known for causing hemorrhagic septicemia in fish and has been linked to gastrointestinal infections in humans. Formalin-inactivated Edwardsiella vaccination has previously been found to be ineffective in aquaculture species. Therefore, based on E. tarda’s integrated core complete sequenced genomes, the study aimed to design a subunit vaccine based on T and B cell epitopes employing immunoinformatics approach. Initially, the top immunodominant and antigenic epitopes were predicted from the core complete sequenced genomes of the E. tarda genome and designed the vaccine by using linkers and adjuvant. In addition, vaccine 3D structure was predicted followed by refinement, and molecular docking was performed for the analysis of interacting residues between vaccines with TLR5, MHC-I, and MHC-II, respectively. The final vaccine constructs demonstrated strong hydrogen bond interactions. Molecular dynamic simulation of vaccine-TLR5 receptor complex showed a stable structural binding and compactness. Furthermore, E. coli used as a model organism for codon optimization proved optimal GC content and CAI value, which were subsequently cloned in vector pET2+ (a). Overall, the findings of the study imply that the designed epitope vaccine might be a good option for prophylaxis for E. tarda.
9
Deml, Michael J., Kristen Jafflin, Sonja Merten, Benedikt Huber, Andrea Buhl, Eleonora Frau, Valérie Mettraux, et al. "Determinants of vaccine hesitancy in Switzerland: study protocol of a mixed-methods national research programme." BMJ Open 9, no. 11 (November 2019): e032218. http://dx.doi.org/10.1136/bmjopen-2019-032218.
Full textAbstract:
IntroductionVaccine hesitancy is a complex public health issue referring to concerns about the safety, efficacy or need for vaccination. Relatively little is known about vaccine hesitancy in Switzerland. This ongoing study (2017–2021) focuses on biomedical and complementary and alternative medicine (CAM) providers and their patients since healthcare professionals play important roles in vaccination decision-making. This national research programme seeks to assess the sociocultural determinants of vaccine hesitancy regarding childhood and human papillomavirus vaccines in Switzerland. We aim to provide a detailed characterisation of vaccine hesitancy, including CAM and biomedical perspectives, patient–provider interactions, and sociocultural factors, to establish the mediating effects of vaccine hesitancy on underimmunisation, and to design an intervention to improve vaccination communication and counselling among physicians, parents and adolescents.Methods and analysisOur transdisciplinary team employs a sequential exploratory mixed-methods study design. We have established a network of more than 150 medical providers across Switzerland, including more than 40 CAM practitioners. For the qualitative component, we conduct interviews with parents, youth, and biomedical and CAM providers and observations of vaccination consultations and school vaccination information sessions. For the quantitative component, a sample of 1350 parents of young children and 722 young adults (15–26 years) and their medical providers respond to questionnaires. We measure vaccine hesitancy with the Parent Attitudes about Childhood Vaccines 15-item survey and review vaccination certificates to assess vaccination status. We administer additional questions based on findings from qualitative research, addressing communication with medical providers, vaccine information sources and perceptions of risk control vis-à-vis vaccine-preventable diseases. The questionnaires capture sociodemographics, political views, religion and spirituality, and moral foundations.Ethics and disseminationThe study was approved by the local ethics committee. The results will be published in peer-reviewed journals and disseminated to healthcare professionals, researchers and the public via conferences and public presentations.
10
Li, Feng X., Marja J. Verhoef, Allan Best, Anthony Otley, and Robert J. Hilsden. "Why patients with inflammatory bowel disease use or do not use complementary and alternative medicine: A Canadian national survey." Canadian Journal of Gastroenterology 19, no. 9 (2005): 567–73. http://dx.doi.org/10.1155/2005/943547.
Full textAbstract:
BACKGROUND: The use of complementary and alternative medicine (CAM) is common in patients with inflammatory bowel disease (IBD).OBJECTIVES: To determine the factors associated with use of CAM, the reasons commonly cited for use or nonuse of CAM, and the correlations between the factors associated with use of CAM and reasons for CAM use.SUBJECTS: The study included 2828 members of the Crohn's and Colitis Foundation of Canada.OBJECTIVE: Subjects were mailed a questionnaire that included items on demographic characteristics, disease and treatment history, health attitudes and behaviours, and reasons for use or nonuse of CAM. Logistical regression was used to determine significant associations with current CAM use.RESULTS: In patients with Crohn's disease and ulcerative colitis, CAM use was associated with more severe disease activity, use of CAM for other purposes, use of exercise and prayer for IBD, and a desire for an active role in treatment decisions. CAM use was also associated with younger age in those with Crohn's disease, and less confidence in their IBD physician in those with ulcerative colitis. The most common reasons for CAM use were a desire for greater control, having heard or read that CAM might help, and the emphasis CAM places on treating the whole person. The most common reasons for not using CAM were that conventional treatments were successful, that not enough was known about CAM and a belief that CAM would not help.CONCLUSION: Disease activity and health attitudes and behaviours, but not demographic characteristics, are associated with CAM use by those with IBD.
11
Al-Beltagi, Sarah, Cristian Alexandru Preda, Leah V. Goulding, Joe James, Juan Pu, Paul Skinner, Zhimin Jiang, et al. "Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus." Viruses 13, no. 2 (February 3, 2021): 234. http://dx.doi.org/10.3390/v13020234.
Full textAbstract:
The long-term control strategy of SARS-CoV-2 and other major respiratory viruses needs to include antivirals to treat acute infections, in addition to the judicious use of effective vaccines. Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use or development for any disease bears testament to the challenges of antiviral development. We recently showed that non-cytotoxic levels of thapsigargin (TG), an inhibitor of the sarcoplasmic/endoplasmic reticulum (ER) Ca2+ ATPase pump, induces a potent host innate immune antiviral response that blocks influenza A virus replication. Here we show that TG is also highly effective in blocking the replication of respiratory syncytial virus (RSV), common cold coronavirus OC43, SARS-CoV-2 and influenza A virus in immortalized or primary human cells. TG’s antiviral performance was significantly better than remdesivir and ribavirin in their respective inhibition of OC43 and RSV. Notably, TG was just as inhibitory to coronaviruses (OC43 and SARS-CoV-2) and influenza viruses (USSR H1N1 and pdm 2009 H1N1) in separate infections as in co-infections. Post-infection oral gavage of acid-stable TG protected mice against a lethal influenza virus challenge. Together with its ability to inhibit the different viruses before or during active infection, and with an antiviral duration of at least 48 h post-TG exposure, we propose that TG (or its derivatives) is a promising broad-spectrum inhibitor against SARS-CoV-2, OC43, RSV and influenza virus.
12
Wheeler, P., and ME Hyland. "Cognitive style predicts use of CAM and attitude to CAM." Focus on Alternative and Complementary Therapies 10 (June 14, 2010): 56. http://dx.doi.org/10.1111/j.2042-7166.2005.tb00538.x.
Full text
13
Kristoffersen, Agnete E., Arne J. Norheim, and Vinjar M. Fønnebø. "Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use." Evidence-Based Complementary and Alternative Medicine 2013 (2013): 1–10. http://dx.doi.org/10.1155/2013/318781.
Full textAbstract:
The associations for CAM use are only occasionally differentiated by gender in populations where both male and female cancer survivors occur. The aim of this study is to describe the prevalence of CAM use in individuals with a previous cancer diagnosis and to investigate gender differences regard to factors associated with use. A total of 12982 men and women filled in a questionnaire with questions about life style and health issues. Eight hundred of those had a previous cancer diagnosis of whom 630 answered three questions concerning CAM use in the last 12 months. A total of 33.8% of all cancer survivors reported CAM use, 39.4% of the women and 27.9% of the men (). The relationship between the demographic variables and being a CAM user differed significantly between men and women with regard to age (), education (), and income (). Female CAM users were more likely to have a university degree than the nonusers, while male CAM users were more likely to have a lower income than the nonusers. According to this study, prevalence and factors associated with CAM use differ significantly between male and female survivors of cancer.
14
AlGhamdi, Khalid M., Huma Khurrum, Sahar H. Al-Natour, Waleed Alghamdi, Thamer Mubki, Abdulatif Alzolibani, Dhafer Mohammed Y. Hafez, and Mohammed AlDraibi. "Use of Complementary and Alternative Medicine Among Dermatology Outpatients." Journal of Cutaneous Medicine and Surgery 19, no. 6 (April 29, 2015): 570–79. http://dx.doi.org/10.1177/1203475415584867.
Full textAbstract:
Background: Little is known about the prevalence and practice of complementary and alternative medicine (CAM) among dermatology patients in the Arab world. The aim of this study was to determine knowledge and attitudes about CAM, prevalence of its use, reasons for its use, and types of CAM used in dermatology patients in Saudi Arabia. Methods: This was a national survey of various regions of Saudi Arabia. In this cross-sectional study, dermatology outpatients were interviewed using a questionnaire. Sociodemographic characteristics, acceptability, utilization pattern, and reasons for CAM use were elicited. Dermatology life quality index (DLQI) was obtained. Results: Overall, 1901 patients returned complete questionnaires out of 2500 distributed (76% response rate). Of these, 808 (40%) were CAM users, and the majority were woman (55.1%), with a mean age of 31.6 ± 12 years. Most were literate (71.2%) and just over half were married (51.9%). Patients with acute skin diseases were found to be more likely to use CAM ( P = .027). The mean DLQI score was higher (worse quality of life) among CAM users than among nonusers ( P = .002). The results showed that 315 of 801 (40%) and 250 of 601 (30%) CAM users agreed that CAM methods are safer and more effective than modern medicine, respectively, and 83% will continue to use CAM in future. The most commonly used CAM modalities were vitamins, prayers, natural products, and herbs. Responses indicated that 379 of 803 (47.2%) CAM users did not consult their doctor before using CAM, and 219 of 743 (30%) did not obtain sufficient answers regarding CAM use from their dermatologists. Conclusions: There is a significant use of CAM among dermatology outpatients in Saudi Arabia. In view of the common belief that CAM has fewer side effects than conventional medicine, dermatologists need to increase their awareness of CAM.
15
Gottschling, Sven, Alfred Langler, Christoph Tautz, and Norbert Graf. "CAM Use in Pediatric Oncology." Current Pediatric Reviews 2, no. 4 (November 1, 2006): 361–68. http://dx.doi.org/10.2174/157339606778699626.
Full text
16
Misra, Sanghamitra M., Danielle Guffey, Isabel Roth, and Angelo P. Giardino. "Complementary and Alternative Medicine Use in Uninsured Children in Texas." Clinical Pediatrics 56, no. 9 (May 18, 2017): 866–69. http://dx.doi.org/10.1177/0009922817709556.
Full textAbstract:
Use of complementary and alternative medicine (CAM) among US children is 12% according to the 2012 National Health Interview Study. Certain pediatric populations have higher CAM use. We studied an uninsured population because limited access to care likely results in higher CAM use. We surveyed 250 uninsured patients in a free pediatric mobile clinic program. In the largely Hispanic population, rate of CAM use in the preceding 12 months was 45% among children and 59% among parents. Ninety-one percent of children who used CAM had parents who used CAM while only 32% of parents used CAM for themselves but did not use CAM for their children ( P < .001). Seven parents (3%) and 4 children (2%) had ever discussed their CAM use with a physician. Since CAM use is significant in this uninsured population and families do not generally discuss CAM with physicians, health care providers must ask about CAM use and provide guidance.
17
Tandon, P., A. N. Sasson, and Z. Gallinger. "A245 IMPROVING KNOWLEDGE TRANSFER OF PREVENTATIVE CARE IN INFLAMMATORY BOWEL DISEASE USING ELECTRONIC LEARNING." Journal of the Canadian Association of Gastroenterology 3, Supplement_1 (February 2020): 122–23. http://dx.doi.org/10.1093/jcag/gwz047.244.
Full textAbstract:
Abstract Background Inflammatory bowel disease (IBD) is a complex chronic disease and it is imperative that gastroenterologists are familiar with the unique needs of the IBD patient. An important part of management involves education surrounding the general health maintenance needs of this patient population, especially those on immunomodulator and biologic therapy or those being considered for such treatment. A recent study showed that Canadian GI trainees are uncomfortable managing preventative care in IBD including vaccinations and bone protection. Using educational videos for trainees to improve core knowledge of these concepts remains unclear. Aims Assess educational efficacy of a core training module on trainee confidence and knowledge on preventative care in IBD. Methods This study assessed a preventative care in IBD video used as an educational tool in the University of Toronto GI trainee program as part of the annual GI in-training objective structured clinical examination (OSCE). Prior to the OSCE, a randomly selected cohort of trainees were provided the preventative care video. The remaining trainees prepared for the OSCE as standard. At the OSCE, one station asked all trainees to address preventative care in IBD with a standardized patient. Following the OSCE, a standardized evaluation of trainee confidence and degree of knowledge on vaccination, cancer screening, bone health, and mental health in IBD patients was performed. These evaluations and OSCE score were then compared between both cohorts. Data was analyzed using a t-test and p<0.05 was considered significant. Results A total of 10 subjects took part in the study. 5 subjects were exposed to the video prior to the OSCE and 5 were not exposed. Overall total score for trainees who had seen the video prior to the OSCE had a mean score of 85.3% (38.4/45) compared to those who had not seen the video prior had a mean score of 65.3% (29.4/45) with a p = 0.03. Global score in those exposed to the video was 70% (3.5/5) compared to 48% (2.4/5) in the unexposed group with a p= 0.006. Upon assessment of individuals topics, there was a trend in improved knowledge of vaccination and mental health screening in those exposed vs. unexposed to the educational video (52.6% vs. 32.6%, and 80% vs. 20%, respectively). No significant difference was identified between groups with respect to cancer screening and bone health. Conclusions Our study shows evidence that use of educational videos was efficacious with respect to GI trainee confidence and knowledge surrounding key concepts in preventative care of IBD patients. This exposure allows for improved patient education and management and lead to better-quality patient care. Overall, this study identifies a knowledge gap in trainee education and highlights the need for development of training tools to improve overall management of this complex and dynamic disease. Funding Agencies CAGVideo was a CAG accredited educational material, and supported by an educational grant from the Canadian Association of Gastroenterology and Abbvie Canada
18
Eisele, Günter, Ulrich Roelcke, Katrin Conen, Fabienne Huber, Tobias Weiss, Silvia Hofer, Oliver Heese, et al. "Complementary and alternative medicine use by glioma patients in Switzerland." Neuro-Oncology Practice 6, no. 3 (October 12, 2018): 237–44. http://dx.doi.org/10.1093/nop/npy035.
Full textAbstract:
Abstract Background During the course of disease, most glioma patients learn that there is no cure for their tumor. It is therefore not uncommon for patients or caregivers to seek complementary and alternative medicine (CAM) treatments. Patterns of CAM use vary across the globe, but little is known about the type of, and motivation for, CAM use in most countries. Methods Here we conducted a cross-sectional survey of CAM use in patients harboring gliomas of World Health Organization (WHO) grades II to IV at 3 specialized neuro-oncology centers in Switzerland. Results Of 208 patients who returned the survey, approximately half reported having used or using CAM. CAM use was associated with younger age. Patients suffering from WHO grade II gliomas were less likely to indicate CAM use. The leading motivation for CAM use was to contribute actively to the treatment of the disease. CAM use was commonly not counseled or supervised by a health care professional. Cost and issues of reimbursement were not an important factor in the decision against or for CAM use. Conclusions Physicians caring for glioma patients should be aware of and explore CAM use to better understand patients’ attitudes toward their disease, to provide counseling, and to identify potential interactions of CAM with standard treatments for gliomas.
19
Sohn, Sangho, Kwan Hong, Hari Hwang, and Byung Chul Chun. "1632. Different Healthcare Utilization Pattern in Vaccine Hesitant Children." Open Forum Infectious Diseases 6, Supplement_2 (October 2019): S595—S596. http://dx.doi.org/10.1093/ofid/ofz360.1496.
Full textAbstract:
Abstract Background National Immunization Program (NIP) in Korea provides 17 types of mandatory vaccines for all children free of charge. However, vaccine-hesitant group refusing the NIP are being a major threat to public health. We analyzed the healthcare utilization pattern observed in NIP eligible children and sought to identify those who remain unvaccinated using national population data. Methods History of receiving protein conjugate pneumococcal vaccine (PCV) was reviewed to determine the vaccination status of children born between 2013 and 2015. Children who had 3-doses or more out of 3 + 1 schedule were defined vaccinated, while those with no record of vaccination were defined unvaccinated. Their healthcare utilization records, including a number of visits, total duration, type of institution (hospitals, complementary and alternative medicine [CAM]), and purpose of visits (outpatient care, hospitalization), were retrieved from the National Health Insurance (NHI) Review and Assessment Service. Annual healthcare utilization rate and incidence of pneumococcal infections were estimated with Poisson regression and compared between study arm. The proportion of CAM out of total healthcare utilization was also compared. Results Among 1,272,685 children, 51% were boys and median age was 29.4-months. Two-percent of the cohort remained unvaccinated until study end. Annual hospital visiting rates were 26.9 times (95% confidence interval [CI] 26.9–27.0) for vaccinated and 3.4 (95% CI 3.4–3.5) for unvaccinated. Average NHI benefit period per year was 28.8 days (95% CI 28.8–29.0) for vaccinated and 3.9 (95% CI 3.8–3.9) for unvaccinated. The discrepancy resulted in under-detection of pneumococcal incidence in unvaccinated with 10.1 cases (95% CI 9.9–10.4) per 1,000 child-months whereas that of vaccinated was 42.5 (95% CI 42.4–42.6). Vaccine hesitant children preferred CAM at least 3-times more than vaccinated children (CAM proportion 3.5% in hesitant group vs. 1.07% in vaccinated group, P < 0.001). Conclusion Vaccine hesitant group not only refuses vaccination but also tends to opt-out from the entire medical attention and prefer CAM. Active detection considering this different pattern should be implemented in order to ensure the public benefits from the vaccination program. Disclosures All authors: No reported disclosures.
20
Luo, Qianlai, and Gary N. Asher. "Complementary and Alternative Medicine Use at a Comprehensive Cancer Center." Integrative Cancer Therapies 16, no. 1 (May 4, 2016): 104–9. http://dx.doi.org/10.1177/1534735416643384.
Full textAbstract:
Background. Complementary and alternative medicine (CAM) use is common among cancer patients, but the majority of CAM studies do not specify the time periods in relation to cancer diagnoses. We sought to define CAM use by cancer patients and investigate factors that might influence changes in CAM use in relation to cancer diagnoses. Methods. We conducted a cross-sectional survey of adults diagnosed with breast, prostate, lung, or colorectal cancer between 2010 and 2012 at the Lineberger Comprehensive Cancer Center. Questionnaires were sent to 1794 patients. Phone calls were made to nonrespondents. Log binomial/Poisson regressions were used to investigate the association between cancer-related changes in CAM use and conversations about CAM use with oncology providers. Results. We received 603 (33.6 %) completed questionnaires. The mean age (SD) was 64 (11) years; 62% were female; 79% were white; and 98% were non-Hispanic. Respondents reported the following cancer types: breast (47%), prostate (27%), colorectal (14%), lung (11%). Eighty-nine percent reported lifetime CAM use. Eighty-five percent reported CAM use during or after initial cancer treatment, with category-specific use as follows: mind-body medicine 39%, dietary supplements 73%, body-based therapies 30%, and energy medicine 49%. During treatment CAM use decreased for all categories except energy medicine. After treatment CAM use returned to pretreatment levels for most CAMs except chiropractic. Initiation of CAM use after cancer diagnosis was positively associated with a patient having a conversation about CAM use with their oncology provider, mainly driven by patient-initiated conversations. Conclusions. Consistent with previous studies, CAM use was common among our study population. Conversations about CAM use with oncology providers appeared to influence cessation of mind-body medicine use after cancer diagnosis.
21
Längler, Alfred, Claudia Spix, Friedrich Edelhäuser, Genn Kameda, Peter Kaatsch, and Georg Seifert. "Use of Homeopathy in Pediatric Oncology in Germany." Evidence-Based Complementary and Alternative Medicine 2011 (2011): 1–7. http://dx.doi.org/10.1155/2011/867151.
Full textAbstract:
Homeopathy is a frequently used complementary and alternative medicine (CAM) treatment. We present results comparing responses of homeopathy users (HUs) and users of other forms of CAM (NHUs) in pediatric oncology (PO) in Germany. Differences between these two groups (usage, associated demographic characteristics, previous experience with CAM) are investigated. 186 (45.2%) of the 367 CAM users were exposed to homeopathy. The treatment duration amounted to a median of 601 days for HUs and 282 days for NHUs. Parents with p (127; 76.5%) also used homeopathy for their child's cancer. Nonmedical practitioners played a considerably greater role as source of information than did treating physician. In the majority HUs received their prescriptions from nonmedical practitioners (56%; 29.4% of NHUs). HUs communicate more frequently with their physicians about the CAM-use (77.7% versus 65.2%) and recommend CAM more often than NHUs (94% versus 85.6%). Homeopathy is the most frequently used CAM treatment in PO in Germany. HUs sustain treatment and therapies considerably longer than NHUs. Most families who had used homeopathy before their child was diagnosed with cancer also used homeopathy for the treatment of their child's cancer. Compared to other CAM treatments, patient satisfaction with homeopathy appears to be very high.
22
Alsabri, Mohammed, Kusum Viswanathan, Fiorella Castillo, Paridhi Ghai, and Maryam Hemmat Hamrah. "Use of Complementary and Alternative Medicine for Children with Sickle Cell Disease: Prevalence and Factors Associated with Use." OBM Integrative and Complementary Medicine 06, no. 02 (December 26, 2020): 1. http://dx.doi.org/10.21926/obm.icm.2102013.
Full textAbstract:
Sickle cell disease (SCD) is one of the most common hematologic disorders in the world. In the United States, it is the single most common genetic hematologic disorder. The burden of SCD and its complications on pediatric patients is tremendous, especially acute vaso-occlusive pain crises. Although allopathic medicine has provided numerous pain medications to treat this, they do not come without side effects and are not always effective. This review explores complementary and alternative medicine (CAM) methods of pain management available for pediatric SCD patients. A PubMed literature search was conducted, and the reference lists of shortlisted studies and review articles were screened after application of the exclusion criteria; 14 articles were used in this literature analysis. A wide range of CAM therapies exist. Common ones include praying, spirituality, and massage. Factors associated with CAM use are parental use of CAM, gender, SCD/pain severity, patient’s age, caregiver’s education level, and in some cases, financial means to access CAM methods. CAM has shown to be effective in reducing pain, patients’ depression and anxiety, analgesic use, and in increasing daily functioning. Thus, CAM has demonstrated potential in reducing pain and improving the quality of life of pediatric SCD patients. It holds great promise to be regularly encouraged by providers and employed by patients. Further research is needed on a larger scale to better study its efficacy; however, CAM use has repeatedly been associated with improved functioning and pain control.
23
Montalto, Catherine P., Vibha Bhargava, and Gong Soog Hong. "Use of Complementary and Alternative Medicine by Older Adults: An Exploratory Study." Complementary health practice review 11, no. 1 (January 2006): 27–46. http://dx.doi.org/10.1177/1533210106288823.
Full textAbstract:
Determinants of complementary and alternative medicine (CAM) use and characteristics of users are examined using a sample of 848 adults aged 50 and older from the 2000 Health and Retirement Survey. Logistic regression is used to identify the factors associated with the likelihood of using CAM. Nearly 70% of the respondents use at least one CAM modality, with 44% reporting use of curative CAM and 58% reporting use of preventive/curative CAM. Whites, relative to Blacks, were more likely to use curative and less likely to use preventive/curative CAM. Widowed older adults were more likely to use preventive/curative CAM. Number of limitations in activities of daily living was positively associated with use of both types of CAM. Recommendations are made for improving research on alternative health care utilization, for educating CAM users, and for qualitative studies to gain further insight into factors affecting the use of specific CAM modalities.
24
Halpin, Sean N., Nivedita R. Potapragaa, Sharon H. Bergquist, and Thomas Jarrett. "AGE AND USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE." Innovation in Aging 3, Supplement_1 (November 2019): S497. http://dx.doi.org/10.1093/geroni/igz038.1842.
Full textAbstract:
Abstract Complementary and alternative medicines (CAM) are often obtained over the counter and not disclosed to health care practitioners—leading to possible unforeseen, harmful drug interactions. These concerns are especially true for older adults who have a high likelihood of experiencing multiple comorbidities. Yet few studies examine the patterns of CAM use and disclosure across a wide age range. We used a mixed-methods in a study on patient attitudes toward CAM in a large primary care setting. Participants (n=279) ranged in age from 21-85 (mean=58), were mostly white (75%), and had a bachelor’s degree or higher (83%). Most rated their physical health as good or very good (90%) and had a score of zero on the Charlson Comorbidity Index (76%). Use and disclosure of twelve types of CAM were assessed across three modalities including ingestible (e.g., herbs), psychological/mind-body (e.g., meditation), and physical (e.g., acupuncture). Age was not predictive of disclosure across the larger sample, but within respondents aged 65-85 (n=90), linear regression analyses showed likelihood of disclosure was associated with younger age, positive attitudes toward CAM, and expectation that their physician had positive attitudes about CAM. Semi-structured phone interviews (n=32) revealed older adults were more likely to have long-term CAM use, particularly for pain, and not feel it necessary to disclose to their physician. Meanwhile younger individuals reported trying CAM episodically for preventative health purposes. Understanding patterns of CAM use can help guide age-appropriate conversations and limit possible adverse outcomes from non-disclosure.
25
Patel, Himadri, KieuHanh Nguyen, Erik Lehman, Gayatra Mainali, Laura Duda, Debra Byler, and Ashutosh Kumar. "Use of Complementary and Alternative Medicine in Children With Tourette Syndrome." Journal of Child Neurology 35, no. 8 (April 1, 2020): 512–16. http://dx.doi.org/10.1177/0883073820913670.
Full textAbstract:
Introduction: Tourette syndrome is a neuropsychiatric condition defined by motor and phonic tics with onset in childhood. Many families have concerns regarding potential side effects of pharmacologic treatments, and often have difficulty accessing comprehensive behavioral intervention for tics. Patients and caregivers may turn to complementary and alternative medicine (CAM) as they perceive these as “natural” and therefore “safe.” Although there are anecdotal reports of an increased use of CAM in Tourette syndrome patients, the exact prevalence is unknown. Objective: The purpose of this study was to identify commonly used CAM therapies for children with Tourette syndrome at Penn State Hershey Medical Center. Methods: A questionnaire was administered to the caregivers of children (<18 years old) via telephone. The data pertaining to demographics, type of CAM use, duration of use, adverse effects, and caregiver’s perception of the effectiveness were collected. Results: A total of 110 patients participated in this survey. When inquired about the different CAM methods, 69.1% of the participants reported using 1 or more CAM therapies, and 58% of those who used CAM informed the doctor about their use. Ninety-three percent of those who used CAM therapy reported a decrease in tic frequency. The most commonly used CAM therapies were stress management (44.6%), herbal medicine (18.2%), homeopathy (12.7%), and meditation (9.1%). In total, 46% of the participants said that CAM helped more than medication. Conclusion: The majority of patients interviewed were using CAM therapies, and a significant portion reported benefit greater than medication. More than half of all participants discussed CAM therapies with their physicians, and 63% of participants felt that their physicians would support their use of CAM therapies.
26
Kvamme, Sinikka L., Michael M. Pedersen, Sagi Alagem-Iversen, and Birgitte Thylstrup. "Beyond the high: Mapping patterns of use and motives for use of cannabis as medicine." Nordic Studies on Alcohol and Drugs 38, no. 3 (February 25, 2021): 270–92. http://dx.doi.org/10.1177/1455072520985967.
Full textAbstract:
Background: In Denmark the boundaries between cannabis as an illicit drug and licit medicine have shifted rapidly in recent years, affecting also policy. However, the vast majority of Danes, who use cannabis as medicine (CaM) continue to rely on the unregulated market for supply. This study explores patterns of use and motives for use of CaM in Denmark. Methods: An anonymous online survey was made available to a convenience sample of users of CaM from July 14, 2018 to November 1, 2018. Participants were recruited through patient organisations, social and public media, and the illegal open cannabis market. Results: Of the final sample ( n = 3,021), a majority were women (62.6%) and the mean age was 49 years. Most had no prescription for CaM (90.9%), a majority had no or limited previous experience with recreational cannabis use (63.9%), and had used CaM for two years or less (65.0%). The most common form of intake was oil (56.8%) followed by smoke (24.0%). CBD oil (65.0%) was used more than hash, pot or skunk (36.2%). Most frequent conditions treated were chronic pain (32.0%), sleep disturbances (27.5%), stress (23.7%), osteoarthritis (22.7%), anxiety (19.6%), and depression (19.6%). Overall, users experienced CaM to be effective in managing somatic and mental health conditions and reported relatively few side-effects. CBD oil only users were more likely to be women, older, have limited recreational experience and have initiated use recently. Conclusions: A new user group has emerged in Denmark that, for the most part, use illegally sourced CaM to treat a broad range of somatic and mental health conditions, often with experienced effect and relatively low level of side-effects. The prevalent use of low-potency CBD oil indicates an interest in effects beyond the high normally associated with cannabis use. More clinical research into the effects and side-effects of CaM is needed to draw the boundaries of the medical utility of cannabis.
27
Emiru, Yohannes Kelifa, Betelhem Anteneh Adamu, Melak Erara, Tigist Chanie, and Abyot Endale Gurmu. "Complementary and Alternative Medicine Use in a Pregnant Population, Northwest Ethiopia." International Journal of Reproductive Medicine 2021 (August 6, 2021): 1–8. http://dx.doi.org/10.1155/2021/8829313.
Full textAbstract:
Background. Complementary and alternative medicine (CAM) appears to be the source of healthcare particularly in the majority of pregnant communities of Africa due to its intrinsic qualities as well as its accessibility and affordability. Despite acknowledged benefits of CAM use in pregnancy, majority of users are unaware of its safety and effects on fetal development. The present study was aimed at examining CAM use among pregnant women in Northwest Ethiopia to provide an opportunity for future investigations on the effectiveness of CAM modalities in the management of pregnancy-related complications across the country. Methods. This was an institution-based cross-sectional study which was conducted at Poly Clinic Health Center in the Northwest part of Ethiopia between March and May 2018. Two hundred and eighty two Ethiopian women were conveniently recruited to take part in the study. Structured questioners were used for the survey. Descriptive statistics of sociodemographic and CAM use characteristics were expressed in frequencies and proportions. Chi-square test was performed to determine the difference between CAM user and nonuser. Besides, binary logistic regression analyses were performed to examine predictors of CAM use in the study population. The result was considered statistically significant if P value ≤ 0.05. Results. The prevalence rate of CAM use in pregnant women was 89.36% with the commonest practice of spiritual healing (65.2%) and herbal supplement (51.8%) CAM therapies. Use of CAM positively associated with marital status and previous number of children. The odds of using CAM among single/not married women were 3.22 times higher (COR: 3.22, CI: 1.07-9.64) as compared to married women. Pregnant women with no children were 3.30 times more likely (COR: 3.30, CI: 0.92-11.84) to use CAM than those women having ≥3 children. Lower odds of using CAM significantly associated with educational level (COR: 0.20, CI: 0.046-0.93) and antenatal care (COR: 0.45, CI: 0.18-1.13) in a binary logistic regression model. Conclusions. A considerable number of pregnant women were utilizing CAM including herbal products as part of their maternity care. This finding provides a reference on the use of CAM for policy-makers, health professionals, and parents. Further studies are needed to investigate the effectiveness and safety of specific CAM modalities with particular focus on herbal medicinal products.
28
Kim, Sungha, Sujeong Mun, Jeonghwan Park, Sunmi Choi, Sanghun Lee, and Sungchul Kim. "Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea." Evidence-Based Complementary and Alternative Medicine 2019 (July 25, 2019): 1–5. http://dx.doi.org/10.1155/2019/4217057.
Full textAbstract:
Patients with amyotrophic lateral sclerosis (ALS) sometimes consider complementary and alternative medicine (CAM) because of ineffective treatment. This study investigated the prevalence and utilization pattern of CAM among patients with ALS in South Korea. Participants were recruited through homecare services for mechanical ventilation in South Korea. This study comprised a face-to-face cross-sectional survey with staff members available to address any queries. Fifty-five participants were included; all had used >1 CAM treatment option for ALS symptoms. Dietary treatments were most common, followed by functional food and massages. Most participants had obtained relevant information from family members or friends. The main reason for CAM use was an expectation that symptoms will improve with CAM; most patients were unsure of the effects. CAM use was previously discontinued by the majority of patients because of unsatisfactory effects. The mean expenditure on CAM was 288,385.28 ± 685,265.14 won per month, and the mean duration of CAM use was 11.54 ± 20.09 months. The results indicate that there is a high prevalence of CAM use among ALS patients. Healthcare providers should inquire about CAM use and openly provide accurate CAM information. Further evidence of CAM efficacy is required, as is specific guidance for consulting ALS patients regarding CAM.
29
Vernon-Roberts, Angharad, Abida Denny, and Andrew S. Day. "Point Prevalence of Complementary or Alternative Medicine Use among Children Attending a Tertiary Care Hospital." Children 10, no. 1 (January 10, 2023): 132. http://dx.doi.org/10.3390/children10010132.
Full textAbstract:
Background: Complementary or alternative medicine (CAM) describes products/practices outside conventional medical care. CAM may be used to support or replace conventional/prescribed therapies. The aim of this study was to determine patterns of CAM use among children attending a tertiary care hospital in New Zealand (NZ) and measure parental opinion about CAM. Methods: Prospective survey-based study among children and their parents attending inpatient and outpatient clinical areas. Surveys collected demographic and health variables, current CAM use, and parental opinions on CAM. Results: Of the 236 children participating: 41% female, mean age 6.8 years (SD5), 76 (32%) with a chronic illness. CAM was used by 132 (56%) children, the most common being: oral supplements, body manipulation methods, or holistic practices. CAM use was associated with lower child health rating (p = 0.001), Māori ethnicity (p = 0.03), parent education level (p = 0.002), and family member CAM use (p < 0.001). Opinion survey results revealed CAM use was most strongly related to doctors recommending CAM, information on CAM, and CAM cost. There was a 31% CAM disclosure rate to the child’s medical team. Conclusions: This study highlights cultural differences in CAM use not previously reported among children in NZ. Parental opinion regarding CAM influences use for their child and disclosure rates.
30
Sharp, Debbie, Ava Lorenc, Richard Morris, Gene Feder, Paul Little, Sandra Hollinghurst, Stewart W. Mercer, and Hugh MacPherson. "Complementary medicine use, views, and experiences: a national survey in England." BJGP Open 2, no. 4 (November 13, 2018): bjgpopen18X101614. http://dx.doi.org/10.3399/bjgpopen18x101614.
Full textAbstract:
BackgroundIn 2005,12% of the English population visited a complementary and alternative medicine (CAM) practitioner.AimTo obtain up-to-date general population figures for practitioner-led CAM use in England, and to discover people's views and experiences regarding access.Design & settingA face-to-face questionnaire survey was commissioned. A nationally representative adult quota sample (aged ≥15 years) was used.MethodTen questions were included within Ipsos MORI’s weekly population-based survey. The questions explored 12-month practitioner-led CAM use, reasons for non-use, views on NHS-provided CAM, and willingness to pay.ResultsOf 4862 adults surveyed, 766 (16%) had seen a CAM practitioner. People most commonly visited CAM practitioners for manual therapies (massage, osteopathy, chiropractic) and acupuncture, as well as yoga, pilates, reflexology, and mindfulness or meditation. Women, people with higher socioeconomic status (SES) and those in south England were more likely to access CAM. Musculoskeletal conditions (mainly back pain) accounted for 68% of use, and mental health 12%. Most was through self-referral (70%) and self-financing. GPs (17%) or NHS professionals (4%) referred and/or recommended CAM to users. These CAM users were more often unemployed, with lower income and social grade, and receiving NHS-funded CAM. Responders were willing to pay varying amounts for CAM; 22% would not pay anything. Almost two in five responders felt NHS funding and GP referral and/or endorsement would increase their CAM use.ConclusionCAM use in England is common for musculoskeletal and mental health problems, but varies by sex, geography, and SES. It is mainly self-referred and self-financed; some is GP-endorsed and/or referred, especially for individuals of lower SES. Researchers, patients, and commissioners should collaborate to research the effectiveness and cost-effectiveness of CAM and consider its availability on the NHS.
31
Chang, Hsiao-yun Annie, Marianne Wallis, and Evelin Tiralongo. "Use of Complementary and Alternative Medicine among People with Type 2 Diabetes in Taiwan: A Cross-Sectional Survey." Evidence-Based Complementary and Alternative Medicine 2011 (2011): 1–8. http://dx.doi.org/10.1155/2011/983792.
Full textAbstract:
Research into CAM use by people with diabetes is limited. This study explored CAM use among patients who attend diabetic clinics for followup treatment. Special attention was paid to patients' changing patterns of CAM use before and after diagnosis with Type 2 diabetes, their experience of CAM use, and their management of CAM use with conventional medicines. A retrospective cross-sectional survey () was undertaken in three census regions in Taiwan, including metropolitan, urban, and rural areas in 2006-7 (87.4% response rate). Participants reported extensive use of CAM with conventional medicines. The prevalence of CAM use was 22.7% before and 61.0% after diagnosis with Type 2 diabetes with nutritional supplements being the most commonly used CAM before and after diagnosis. However, the disclosure rate of CAM use to healthcare professionals remained low (24.6%), and lack of knowledge about CAM ingredients was common (63.4%). Awareness of the widespread use of CAM by people with Type 2 diabetes is crucial for healthcare professionals. The self-administration of both conventional medicines and CAM without disclosure of CAM use to healthcare professionals may result in ineffective diabetes management and adverse effects. CAM information needs to be incorporated into clinical practice and patient and professional education.
32
Wu, Alex, Yunhong Wu, PRABHSIMRANJOT SINGH, Vijaya Natarajan, Waseem Cheema, Rukhsana Hossain, Christine Liu, et al. "Complementary and alternative medicine (CAM) use in cancer patients of immigration background." Journal of Clinical Oncology 39, no. 15_suppl (May 20, 2021): 12019. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.12019.
Full textAbstract:
12019 Background: Cancer patients are more likely to use complementary and alternative medicine (CAM) than non-cancer patients for immune enhancement and symptom relief. Cancer patients with immigration background may seek out CAM use more readily due to the influence from their cultural background. Methods: We carried out a prospective questionnaire study surveying the use of 21 CAM types to cancer patients between 10/23/2015 and 10/31/2020, to evaluate the association of CAM use with patients’ age, sex, cancer types, stages, race/ethnicity, birthplace, immigration duration, first language, marital status, levels of poverty, education and anxiety. Results: 658 patients were included in this analysis. The median age was 62 years old. The prevalence of CAM use was 66.11%. CAM use was higher in females (71.98%) than the males (54.34%) (p = 1.13x10-5), and higher in patients ≥ 38 years old (67.09%) than < 38 years old (46.88%) (p = 0.0215). Patients of African American descent (both US born and foreign born) (n = 198) had statistically higher CAM use (72.73%) than the Caucasians and Others (including Middle-Eastern, Multi-Racial and Others) (n = 266) (63.53%) (p = 0.0371). There was no difference of CAM use between the US born patients (n = 301, CAM use 68.77%) and the immigrants (n = 347, CAM use 63.98%) as a whole; however, Asian born immigrants (n = 106) had statistically less CAM use (53.77%) than the US born and other non-Latin American born (n = 397, CAM use 66.50%) (p = 0.0161), while the Latin-American born had a trend towards higher CAM use (74.83%, P = 0.0608). The number of years living in the US by the immigrants did not have an association with CAM use. Among psychosocial economic factors, married patients had a lower CAM use (61.23%) than the unmarried group (defined as divorced, separated, widowed, or single status, 70.85%) (p = 0.0102). The levels of education, poverty and anxiety did not show a statistical difference in relation to CAM use. Earlier stages of disease had numerically higher CAM use than stage 4 patients, and patients with breast and GYN cancers had higher CAM use (72.30%, p = 0.00252), consistent with the data on the higher CAM use in females. Prayer and spirituality and Dietary medicine were the 2 most common CAM types used (25.91% and 16.12%, respectively). African Americans of the combined US and Non-US origin showed the highest rate of using Prayer and spirituality (84.72%), versus Hispanics (71.19%), Caucasians (53.85%), and Asians (40.32%). Chiropractic therapy was exclusively used by Caucasian CAM users (9.38%). Conclusions: Among cancer patients of multi-ethnic groups with immigration background served in a community hospital in Brooklyn, New York, CAM use appeared to be higher in the African American patients, and lower in the patients born in Eastern Asia, as compared to the US born, or to Caucasians. Cultural roots appeared to be a strong influencing factor among all the medical and socioeconomic factors.
33
Hammersen, Friederike, Telja Pursche, Dorothea Fischer, Alexander Katalinic, and Annika Waldmann. "Use of Complementary and Alternative Medicine among Young Patients with Breast Cancer." Breast Care 15, no. 2 (July 19, 2019): 163–70. http://dx.doi.org/10.1159/000501193.
Full textAbstract:
Background: Complementary and alternative medicine (CAM) has received increasing attention in Western countries and is especially common among breast cancer (BC) patients. So far, its effectiveness has not been well studied, which is in part due to the contextuality of CAM along with a lack of information of why patients use it. Objectives: Young BC patients constitute a special patient group regarding clinical characteristics, QOL, and their role in society. Since little is known about their CAM use, this study aimed at exploring it as well as their reasons for CAM use. Methods: Data on CAM and sociodemographics were collected via questionnaire in the context of a rehabilitation program for young mothers with BC. Initial BC diagnoses were between 2009 and 2014 (recruitment period 2012–2015). Clinical characteristics were derived from the patient files. Descriptive statistics were used to describe frequencies and statistically significant differences were tested. Results: Among the 827 patients, with an average age of 39.6 years, 62.5% had used CAM with regard to their cancer. CAM use was significantly higher in women with higher educational level, higher employment status, and statutory health insurance, respectively. The average monthly expenses on CAM were EUR 50. Every 5th woman used CAM without her physician’s knowledge. The types most often used were dietary supplements with vitamins or minerals. The most frequent reasons for CAM use were to strengthen the immune system, support conventional medicine, and combat side effects. Conclusions: CAM plays an important role for young BC patients with regard to prevalence and monthly expenses, and was used for a wide range of reasons. Certain subgroups with more frequent CAM use could be identified. Physicians should therefore proactively talk about CAM with their young BC patients, so that patients do not need to rely on information sources on CAM outside the medical system.
34
Hilkert, Sarah M., Naz Askari, Jan D. Hirsch, and Shira L. Robbins. "Use of Complementary and Alternative Medicine Among Pediatric Ophthalmology Patients in San Diego, California." European Journal for Person Centered Healthcare 2, no. 3 (July 15, 2014): 346. http://dx.doi.org/10.5750/ejpch.v2i3.738.
Full textAbstract:
Objectives: Complementary and Alternative Medicine (CAM) has become increasingly common in pediatrics. While previous studies have evaluated pediatric CAM use across various subspecialties, estimates regarding pediatric CAM use in ophthalmology are lacking. This study explores CAM use among pediatric ophthalmology patients in a pediatric ophthalmology practice.Methods: 609 self-report questionnaires were distributed to parents whose children were seen at the University of California, San Diego / Ratner Children’s Eye Center between July 2009 and January 2010. The survey included questions regarding demographic information of the parent, eye condition of the child, and CAM use by the child. The two main outcomes were CAM use in the past and preference for CAM use in the future. Results: 126 surveys were included in the final analysis. Overall, 11% of parents reported previous CAM use for their child’s eye condition, and 44% of parents indicated a preference for CAM use for their child’s eye condition, depending on the side effects. Logistic regression revealed that past CAM use was not associated with the parent’s race, gender, or level of education. However, CAM preference was negatively associated with the parent’s level of education (p = 0.045). Discussion: As with other pediatric subspecialties, treatment of children with CAM is common in pediatric ophthalmology. Given the significant number of parents who reported using CAM and/or a preference for CAM, our results emphasize the need for all pharmacists, ophthalmologists, and pediatricians to discuss CAM use with patients and their families.
35
Chow, Wen Hann, Pearlly Chang, Soo Chin Lee, Alvin Wong, Han-Ming Shen, and Helena Marieke Verkooijen. "Complementary and Alternative Medicine among Singapore Cancer Patients." Annals of the Academy of Medicine, Singapore 39, no. 2 (February 15, 2010): 129–35. http://dx.doi.org/10.47102/annals-acadmedsg.v39n2p129.
Full textAbstract:
Introduction: This study evaluates determinants, expectations, association with quality of life (QOL) and doctor’s awareness of Complementary and Alternative Medicine (CAM) use in Singapore cancer patients. Material and Methods: We interviewed 316 patients visiting the Cancer Centre of the National University Hospital on behaviour, attitudes and expectations towards CAM and assessed QOL via Euroqol Questionnaire (EQ-5D). Medical information was obtained from oncologists. Results: One hundred and seventy-three patients (55%) reported CAM use after cancer diagnosis. Chinese ethnicity, tertiary education, age <65 years and previous CAM use were independent predictors of CAM use. Fifty-one per cent of CAM users informed their doctors about their use and 15% of doctors reported to be aware of CAM use in these patients. Thirty-seven per cent believed CAM to be equally or more effective than conventional cancer therapies and 78% expected at least basic knowledge about CAM from their oncologists. Twenty-five per cent of patients reported concurrent use of oral CAM and chemotherapy, of which oncologists were unaware in 86% of cases. CAM users had higher EuroQol utility scores than non-CAM users (0.79 versus 0.73, respectively, P = 0.03), in particularly those aged ≥65 years and those with stage IV disease. Conclusion: Singapore cancer patients show high prevalence of CAM use, high expectations regarding its effectiveness and doctors’ knowledge on CAM and many use it concurrently with chemotherapy or radiotherapy. Since oncologists are generally unaware of CAM use in their patients, doctor-patient communication on CAM use needs to be improved. The association of CAM use and higher QOL scores in some subgroups deserves further exploration. Key words: Oncology, Patients’ expectations, Quality of life, Survey
36
Bilgili, SG, HU Ozkol, AS Karadag, and O. Calka. "The use of complementary and alternative medicine among dermatology outpatients in Eastern Turkey." Human & Experimental Toxicology 33, no. 2 (July 8, 2013): 214–21. http://dx.doi.org/10.1177/0960327113494904.
Full textAbstract:
Introduction: Over the past decade, complementary and alternative medicine (CAM) has become increasingly popular around the world. Objectives: In this study, we aim to investigate how frequently CAM is used and the types of CAM methods used for dermatological disease in Eastern Turkey. Materials and methods: We recruited 1610 patients from our clinic for this study. The sociodemographic features and the CAM methods were investigated with a survey. Results: The most common dermatological disorders included contact dermatitis (21.4%), acne vulgaris (17.5%), fungal infections (10.9%), eczema (6.3%), and warts (5.7%). The ratio of patients using at least one CAM method was 43.7% and that of those using two or more CAM methods was 20.8%. The most commonly used CAM methods were those using henna, cologne, moisturizing cream, prayer, and herbal therapy. Some patients were found to use some interesting and unusual CAM methods, such as putting out a cigarette over the skin on the back for anthrax, applying raw meat for furuncle, using fuel oil and nitric acid for contact dermatitis. Conclusions: CAM methods are commonly used in our population. CAM methods often cause adverse reactions that may alter diagnostic skin findings and interfere with the efficacy of other medical therapies. Therefore, physicians should ask their patients about the use of CAM methods while collecting patient history. Physicians have a critical role in preventing improper use of CAM. In addition, further investigations into the efficacy, benefits, and risks of CAM methods should be carried out for better insight into those CAM methods.
37
Coleman, Mitchell, and Robert Westermann. "Are Chondrocytes Overlying Cam Morphology Suitable for Therapeutic Use?" Orthopaedic Journal of Sports Medicine 8, no. 7_suppl6 (July 1, 2020): 2325967120S0042. http://dx.doi.org/10.1177/2325967120s00421.
Full textAbstract:
Objectives: Cam-type femoroacetabular impingement (FAI) results in extra bone and cartilage on the anterolateral femoral head-neck junction, causing abnormal contact between the femur and the acetabulum. We investigated whether chondrocytes isolated from cam lesions in FAI patients are metabolically similar to normal chondrocytes and therefore a potential option for therapeutic use via autologous implantation. Methods: Cam cartilage was obtained intraoperatively from 7 human patients with cam lesions (Alpha angle > 60 degrees) (4 arthroscopy, 2 arthroplasty, and 1 periacetabular osteotomy). Healthy femoral and acetabular articular cartilage was obtained from 8 Yucatan minipig hips for comparison. Chondrocytes were extracted from the cartilage then cultured at a high density for up to 1 week. Mitochondrial stress testing procedures (with 2 mM oligomycin, 2.5 mM carbonyl cyanide p-trifluoromethoxy-phenylhydrazone (FCCP), 2 mM rotenone, 5 mM antimycin A) for determination of the chondrocytes basal and maximal respiration were performed. Results: No significant differences in basal (p = 0.73) or maximum (p = 0.40) respiration were found when comparing chondrocytes from cam lesions to normal porcine articular chondrocytes. There was a significant difference in maximum respiration when comparing chondrocytes from cam lesions in patients who underwent a total hip arthroplasty to chondrocytes from other cam lesions (p = 0.007). Conclusion: Basal and maximum respiration in chondrocytes from cartilage overlying cam lesions suggests a similar level of respiration to healthy articular chondrocytes. Given the importance of mitochondria to cartilage homeostasis, this study supports that chondrocytes overlying non-arthritic femoral cam lesions may be a novel source of healthy chondrocytes.
38
Soo, Isaac, Jean K. Mah, Karen Barlow, Lorie Hamiwka, and Elaine Wirrell. "Use of Complementary and Alternative Medical Therapies in a Pediatric Neurology Clinic." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 32, no. 4 (May 2005): 524–28. http://dx.doi.org/10.1017/s0317167100004558.
Full textAbstract:
ABSTRACT:Background:Complementary and alternative medicine (CAM) is increasingly used in adults and children. Studies on CAM in neurological disorders have focused on the adult population and its use among pediatric neurology patients has not been well characterized.Objectives:The purpose of this study was: 1) To characterize the prevalence of CAM in pediatric neurology patients; 2) To determine the perceived effectiveness of CAM in these children; 3) To compare the cost of CAM with conventional therapies; and 4) To describe caregiver or patient-related variables associated with the use of CAM.Methods:This was a cross-sectional survey of patients and families attending the Alberta Children's Hospital neurology clinic between February and May 2004. Patients were considered eligible if they were between two and 18 years of age and had a known history of neurological disorders. Caregivers completed several self-administered questionnaires regarding their socio-demographic profile, their child's neurological illness, and their experience with CAM. Caregivers also rated their child's quality of life using the Pediatric Quality of Life Inventory.Results:One hundred and five of 228 (46%) families completed the survey. The mean age of the neurology patients was 9.8 ± 4.5 years. Forty-six (44%) out of 105 patients received one or more types of CAM, with the most common types being chiropractic manipulations (15%), dietary therapy (12%), herbal remedies (8%), homeopathy (8%), and prayer/faith healing (8%). Caregivers' sociodemographic variables or pediatric health-related quality of life were not significantly associated with the use of CAM. Fifty-nine percent of CAM users reported benefits, and only one patient experienced side effects. There was no significant difference in the total median cost of CAM compared to conventional therapies ($31.70 vs. $50.00 per month). Caregivers' personal experience or success stories from friends and media were common reasons for trying CAM.Conclusions:The use of CAM was common among pediatric neurology patients. Over half of the families reported benefits with CAM, and side effects were perceived to be few. Physicians should initiate discussion on CAM during clinic visits so that the families and patients can make informed decisions about using CAM. Further studies should address the specific role of CAM in children with neurological disorders, and to determine the potential interactions between CAM and conventional therapies in these patients.
39
Parkman, Cynthia A. "Screening for Use of CAM Therapies." Case Manager 11, no. 5 (September 2000): 33–35. http://dx.doi.org/10.1067/mcm.2000.110319.
Full text
40
Bockelbrink, A., J. Ring, HE Wichmann, and T. Schäfer. "CAM in allergies - determinants of use." Focus on Alternative and Complementary Therapies 9 (June 14, 2010): 7. http://dx.doi.org/10.1111/j.2042-7166.2004.tb04496.x.
Full text
41
Smith, Graeme D. "The use of CAM in gastroenterology." Gastrointestinal Nursing 9, no. 4 (May 2011): 5. http://dx.doi.org/10.12968/gasn.2011.9.4.5.
Full text
42
Wendling, Patrice. "CAM Use High Among Autism Patients." Family Practice News 35, no. 4 (February 2005): 43. http://dx.doi.org/10.1016/s0300-7073(05)71452-3.
Full text
43
SCHNEIDER, MARY ELLEN. "IOM: CAM Should Use Conventional Standards." Clinical Psychiatry News 33, no. 3 (March 2005): 97. http://dx.doi.org/10.1016/s0270-6644(05)70105-3.
Full text
44
Kim, D., M. Lee, B. Kim, K. Lee, and Y. Hong. "Use of complementary and alternative medicine in Korean cancer patients: Results of a survey from the Korean Cancer Study Group (KCSG)." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 17061. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.17061.
Full textAbstract:
17061 Background: The aim of this study was to explore the use of complementary and alternative medicine (CAM) in cancer patients of Korea. This study was performed to identify the prevalence, types, subjective effects, and side effects of CAM use, reasons for CAM use, and patients' expectations of doctors regarding their CAM use among Korean cancer patients. Methods: From August to December, 2006, face to face structured interviews were conducted and the data were analyzed in the KCSG. Results: A total 251 patients were recruited. 84% of patients had used at least one type of CAM since the time of initial diagnosis. The most prevalent types of CAM used by these patients included special diet (60%), ginseong (54%), medicinal mushrooms (50%). Energy therapies, acupuncture and spiritual therapy were used uncommonly. The main reported reason for the use of CAM was to feel hopeful. Patients expected that CAM could cure cancer (64%) and improve immune system (52%). 62 % of patients did not inform their physicians about their CAM use. Patients attributed the reason of nondisclosure that physicians never asked about CAM (43%) and physicians would disapprove the CAM use (23%). 6% of CAM users experienced side effects. Demographic variables were not predictive for the use of CAM. 60% of patients wanted to get more information about CAM with their doctors. Conclusions: More than two-thirds of cancer patients used various kinds of CAM. Physicians treating cancer patients should aware of the frequency of CAM use and should share their opinion about CAM use with cancer patients. In order to help patients make informed decisions, physician should pay more attention to CAM for making appropriate utilization of CAM. No significant financial relationships to disclose.
45
Wilkinson, Jenny M., and Paul Tinley. "Knowledge, Beliefs, and Use of Complementary and Alternative Medicine by Australian Podiatric Physicians." Journal of the American Podiatric Medical Association 99, no. 2 (March 1, 2009): 121–28. http://dx.doi.org/10.7547/0980121.
Full textAbstract:
Background: Complementary and alternative medicine (CAM) is one of the fastest growing areas of health care. This has necessitated an increased awareness and understanding of CAM by conventional health professionals. Methods: A questionnaire seeking information about use of and attitudes toward CAM was mailed to 1,365 Australian podiatric physicians. Results: Ninety-one percent of Australian podiatric physicians surveyed have used at least one CAM therapy in the past 12 months, and 93% have treated patients with CAM or have recommended its use to patients. Overall, the respondents rated their knowledge of various CAM therapies as “average,” and responses on the CAM Health Belief Questionnaire indicated that respondents tended not to endorse CAM health beliefs, with statements about CAM therapies being seen as “a threat to public safety” and effects being “usually due to the placebo effect” producing the strongest responses. Conclusions: Complementary and alternative medicine therapies are already being used in podiatric medical practice, and there are significant opportunities for further research into CAM education and clinical research relevant to podiatric medicine. (J Am Podiatr Med Assoc 99(2): 121–128, 2009)
46
Barkla, Bronwyn J., and Timothy Rhodes. "Use of infrared thermography for monitoring crassulacean acid metabolism." Functional Plant Biology 44, no. 1 (2017): 46. http://dx.doi.org/10.1071/fp16210.
Full textAbstract:
Crassulacean acid metabolism (CAM) is an alternative carbon fixation pathway that imparts high water-use efficiency in plants adapted to warm, semiarid climates. With concerns that global warming will negatively influence crop production, turning agricultural focus towards CAM plants may provide a solution to increase productivity using either unconventional crops on marginal land or incorporating CAM molecular mechanisms into conventional crops and improving water-use efficiency. For this to be feasible, deeper insights into CAM pathway regulation are essential. To facilitate this research new tools which simplify procedures for detecting and measuring CAM are needed. Here we describe a non-invasive, non-destructive, simplified method using infrared thermography for monitoring CAM in the annual desert succulent Mesembryanthemum crystallinum L. via detection of changes in leaf temperature brought about by the absence of transpiration due to daytime reduction in stomatal conductance. This method is sensitive, measuring temperature differences of ± 1°C, can be used in both the field and green house and is not restricted by leaf architecture. It offers an alternative to the commonly used gas exchange methods to measure CAM that are technically difficult to acquire and require the use of expensive and cumbersome equipment.
47
Chukasemrat, Nuntorn, Chuenkamon Charakorn, and Arb-aroon Lertkhachonsuk. "The Use of Complementary and Alternative Medicine in Thai Gynecologic Oncology Patients: Influencing Factors." Evidence-Based Complementary and Alternative Medicine 2021 (November 10, 2021): 1–8. http://dx.doi.org/10.1155/2021/1322390.
Full textAbstract:
Background. To determine the factors influencing the use of complementary and alternative medicine (CAM) in gynecologic cancer patients and the prevalence and pattern of CAM use. Methods. This was a cross-sectional study of 370 gynecologic cancer patients conducted at the outpatient clinic, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. After obtaining informed consent, participants were asked to complete a standardized questionnaire including sociodemographic and clinical characteristics, detail of CAM use, attitude of CAM use, and quality of life using EORTC-QLQ-C30. Results. The prevalence of CAM use was 25.13%. The most common type was herbal medicine (55.90%). The participants who resided or had a birthplace in rural areas presented with a higher proportion of CAM use than those in urban areas ( P = 0.470 and P = 0.004 , respectively). Participants who received multiple modalities of cancer treatment reported a significantly higher proportion of CAM use ( P = 0.024 ). Most CAM users agreed that the CAM could be used in combination with standard treatment, and some rather disagreed that CAM could interrupt the treatment effect of the conventional treatment. CAM users had significantly higher role functioning in quality-of-life scores. Conclusion. Factors influencing CAM use in gynecologic cancer patients were rural area birthplace or residency, receiving multiple modalities of cancer treatment, having positive attitude toward CAM use. CAM users had better performance in role functioning in the quality-of-life score. Therefore, gynecologic oncologists should pay attention to these factors in order to communicate with gynecologic cancer patients about CAM use.
48
Misra, Sanghamitra M., Danielle Guffey, Xuan Tran, and Angelo P. Giardino. "Survey of Complementary and Alternative Medicine (CAM) Services in Freestanding US Children’s Hospitals." Clinical Pediatrics 56, no. 1 (July 20, 2016): 33–36. http://dx.doi.org/10.1177/0009922816645513.
Full textAbstract:
Complementary and alternative medicine (CAM) use among US children in 2012 was 11.6%, and studies show CAM use as high as 76% in certain pediatric populations. Children’s hospitals offer varied CAM services. This survey aimed to identify CAM services offered, the structure of CAM departments, and supplement use policies in freestanding US children’s hospitals. In our survey, 92% of responding children’s hospitals offered CAM services, and 38% had hospital-based CAM centers; 60% of responders had policies for supplement use during hospitalization, whereas only 40% had policies for supplement use surrounding surgery. CAM services are widely offered in freestanding US children’s hospitals, but most do not have CAM departments. Many hospitals do not have written policies about supplement use. A better understanding of CAM services, programs, and supplement use policies are needed to bring more coordinated services and safer policies to children’s hospitals.
49
Wallen, Gwenyth R., and Alyssa T. Brooks. "To Tell or Not to Tell: Shared Decision Making, CAM Use and Disclosure among Underserved Patients with Rheumatic Diseases." Integrative Medicine Insights 7 (January 2012): IMI.S10333. http://dx.doi.org/10.4137/imi.s10333.
Full textAbstract:
The purpose of this analysis was to assess the impact of perceived shared decision-making (SDM) on complementary and alternative medicine (CAM) use and disclosure in a sample of urban, underserved minority patients (n = 109) with rheumatic diseases. Nearly three quarters of the patients (71.6%) reported CAM use. Of these, 59% disclosed CAM use to their provider. Logistic regression models were created. In model 1 SDM significantly predicted CAM use; however, the overall model fit was not significant. In model 2, gender, ethnicity, and SDM predicted CAM disclosure with 73.2% correctly classified. Females were more likely and Hispanics were less likely to disclose CAM use. Those with higher SDM scores were more likely to disclose CAM use. SDM played a role in whether patients used CAM and disclosed CAM use to their providers. Improving SDM strategies may be especially important among patients who are least likely to disclose CAM use.
50
Hu, Huanhuan, Gang Li, Jiali Duan, and Takashi Arao. "Prevalence, Purposes, and Perceived Effectiveness of Complementary and Alternative Medicine Use in a Hypertension Population: A Questionnaire Survey." ISRN Public Health 2013 (December 25, 2013): 1–7. http://dx.doi.org/10.1155/2013/137472.
Full textAbstract:
Complementary and alternative medicine (CAM) is widely used among patients with hypertension. This study aimed to determine the use of CAM in community-dwelling individuals with hypertension. A cross-sectional questionnaire survey was administered to 318 hypertension patients to examine prevalence and patterns of CAM use; the use of CAM, specifically for treatment of hypertension or other conditions, and perceived effectiveness of CAM were examined. CAM use in the last 12 months was reported by 236 (74.2%) participants. Only 13.1% of these CAM users reported using CAM to treat hypertension. CAM users did not differ statistically from non-CAM users by age, marital status, health status, duration of hypertension, income, or education. Females showed a significantly higher prevalence of CAM use than that of males (OR 1.82, 95% CI 1.09, 3.11). Family/relatives, doctors, and patients themselves were the three main sources of information about CAM. More than 70% of responses were able to perceive the effectiveness of alternative medical systems, mind-body medicine, and manipulative/body-based therapies. There was a high prevalence of CAM use among hypertension patients, although the majority of CAM use was not specifically for hypertension. Further research is needed to assess the safety and efficacy of diverse CAM.